John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

Radioembolization for intra-hepatic cholangiocarcinoma and liver metastasis of colorectal cancer: where are we now? Volume 24, issue 2, Février 2017

Figures

  • Figure 1

Tables

Authors
1 Centre Eugène Marquis,
service d’oncologie médicale,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
2 Centre Eugène Marquis,
service de radiodiagnostic et radiologie interventionnelle,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
3 Centre Eugène Marquis,
service de médecine nucléaire,
Rue de la Bataille Flandres Dunkerque,
35000 Rennes,
France
* Tirés à part

Selective internal radiation therapy has been developed since the 80’ with various vectors (lipiodol, micro beads) and radionuclides (131I, 90Y, 88Re). This therapeutic option is now ready for daily practice in several primary liver tumors as well as in liver metastases. Its definitive position in the future therapeutic guidelines will depend on the results of the ongoing phase 2 and 3 clinical trials. Here, we review the available data concerning selective internal radiation therapy and mass-forming cholangiocarcinoma on one hand and colorectal cancer liver metastases on the other hand.